Tumor Type

Australia
Ovarian Cancer - Serous cystadenocarcinoma
Project Profile
Funding Organizations
Research Organizations
Research Activities
Publication Policy

1:   QCMG Project Specific Moratorium HTML 
2:   ICGC Goals, Structure, Policies and Guidelines Section E.3 - Publication Policy HTML 
3:   Template Letters to Facilitate Communications HTML 
to ensure appropriate dialogue between data users and generators and for authors to contact ICGC members and editors
Clinic & Pathology

Australia: Australian Ovarian Cancer Study
Peter MacCallum Cancer Centre
Sequencing & Analysis

Australia: Institute for Molecular Bioscience
Complementary Studies

Australia: Institute for Molecular Bioscience
Peter MacCallum Cancer Centre
Data Storage, Analysis & Management

Australia: Institute for Molecular Bioscience
Peter MacCallum Cancer Centre
Project Summary

The primary aims sequence largely paired primary and recurrent ovarian tumors primarily drawn from a population based cohort study, the Australian Ovarian Cancer Study. The studies will define the somatic genomic abnormalities in primary ovarian tumours and insights into the molecular drivers of primary and acquired platinum resistance.

Principal Investigators

Institute for Molecular Bioscience
• Sean M. Grimmond (overall lead)
• David Miller
• Conrad Leonard
• Nicola Waddell
• Peter Wilson
• John V. Pearson
• Karin Kassahn

Peter MacCallum Cancer Centre
• David Bowtell (ovarian cancer lead)
• Dariush Etemadmoghadam

Westmead Millennium Institute for Medical Research
• Anna de Fazio

Queensland Institute for Medical Research
• Adèle Green
• Georgia Chenevix-Trench
• Penelope Webb
• David Whiteman
• David Purdie

Lead Jurisdiction